Clinical Utility of Evolocumab in the Management of Hyperlipidemia: Patient Selection and Follow-Up

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s114091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Does Histopathological Examination of Breast Reduction Specimens Affect Patient Management and Clinical Follow Up?

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2004English

Clinical Follow-Up of the First SF-1 Insufficient Female Patient

Annales d'Endocrinologie
MedicineEndocrinologyMetabolismDiabetes
2017English

Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients With Mixed Hyperlipidemia

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2016English

Patient Radiation Dose Management in the Follow-Up of Potential Skin Injuries in Neuroradiology

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2012English

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia

Journal of the American Heart Association
Cardiovascular MedicineCardiology
2017English

Valsartan Combination Therapy in the Management of Hypertension &Ndash; Patient Perspectives and Clinical Utility

Integrated Blood Pressure Control
Internal MedicineCardiovascular MedicineCardiology
2009English

Figure 1: Flowchart for Patient Selection and Follow-Up Until ICU Discharge.

English

Follow-Up Clinical Electrophysiological Studies in a Patient With Myotonic Dystrophy.

Japanese Journal of Medicine
1991English

Two-Tiered Subdivision of Atypia on Urine Cytology Can Improve Patient Follow-Up and Optimize the Utility of UroVysion

Cancer cytopathology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy